{"@context":{"ns0":"http://www.ebi.ac.uk/efo/","rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","owl":"http://www.w3.org/2002/07/owl#","rdfs":"http://www.w3.org/2000/01/rdf-schema#","obo_purl":"http://purl.obolibrary.org/obo/","metadata_def":"http://data.bioontology.org/metadata/def/","metadata":"http://data.bioontology.org/metadata/"},"@id":"ns0:EFO_0007784","@type":"owl:Class","rdfs:subClassOf":{"@id":"ns0:EFO_0001444"},"rdfs:label":"functional decline measurement","obo_purl:IAO_0000115":"quantification of some aspect of muscle function deterioration such as the rate at which it occurs or its severity, for example in patients with neurodegenerative conditions such as ALS. Functional decline is ususally assessed using a combination of physical exams and structured-interview protocols covering a number of standardised areas.","obo_purl:IAO_0000117":"Dani Welter","ns0:gwas_trait":{"@type":"http://www.w3.org/2001/XMLSchema#boolean","@value":"1"},"metadata:def/prefLabel":"functional decline measurement","metadata:def/mappingLoom":"functionaldeclinemeasurement","metadata:def/mappingSameURI":{"@id":"ns0:EFO_0007784"},"metadata:prefixIRI":"efo:EFO_0007784"}